Every patient with suspected sarcoid cardiomyopathy must be thoroughly investigated to make sure it is not TB masquerading as sarcoid
IMH has poorer prognosis than patients with MVO without IMH or without MVO
FAP uptake in the myocardium is always abnormal and should be reported and then worked up for ischemic or non-ischemic etiologies of fibrosis, if the patient is not a known case of cardiac disease.
